P3‐029: EFFICACY AND SAFETY OF OXIRACETAM IN PATIENTS WITH VASCULAR COGNITIVE IMPAIRMENT (OVERCOME): DESIGN AND RATIONALE FOR A MULTICENTER, RANDOMIZED, DOUBLE‐BLINDED, PLACEBO‐CONTROLLED, PARALLEL‐DESIGN, PHASE IV CLINICAL TRIAL

Authors :: Hee-Joon Bae
Jong-Moo Park
Kyung Bok Lee
Byung-Chul Lee
Juneyoung Lee
Jae-Hyeok Heo
Beom Joon Kim
Jae-Sung Lim
Dong-Eog Kim
Tai Hwan Park
Hyuntae Park
Kyung-Ho Yu
Mi-Sun Oh
Jae-Kwan Cha
Yeonwook Kang
Source :: Alzheimer's & Dementia. 14
Publication Year :: 2018
Publisher :: Wiley, 2018.

Subjects :: Epidemiology
Double blinded
business.industry
Health Policy
Parallel design
Placebo
Clinical trial
Psychiatry and Mental health
Cellular and Molecular Neuroscience
Developmental Neuroscience
Anesthesia
Medicine
Oxiracetam
In patient
Neurology (clinical)
Geriatrics and Gerontology
business
Cognitive impairment
medicine.drug

Full Text Access

Tools